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Standardized assessment of walking capacity
after spinal cord injury: the European
network approach
H. J. A. van Hedel*{, M. Wirz*{ and V. Dietz*{
*Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland
{EM-SCI Group, Zurich, Switzerland
Objectives: After a spinal cord injury (SCI), walking function is an important outcome measure
for rehabilitation and new treatment interventions. The current status of four walking capacity
tests that are applied to SCI subjects is presented: the revised walking index for spinal cord injury
(WISCI II), the 6 minute walk test (6MinWT), 10 meter walk test (10MWT) and the timed up and
go (TUG) test. Then, we investigated which categories of the WISCI II apply to SCI subjects who
participated in the European Multicenter Study of Human Spinal Cord Injury (EM-SCI), and the
relationship between the 10MWT and the TUG.
Methods: In the EM-SCI, the walking tests were applied 2 weeks and 1, 3, 6 and 12 months after
SCI. We identified the WISCI II categories that applied to the EM-SCI subjects at each time point
and quantified the relationship between the 10MWT and the TUG using Spearman’s correlation
coefficients (r) and linear regression.
Results: Five WISCI II categories applied to 71% of the EM-SCI subjects with walking ability,
while 11 items applied to 11% of the subjects. The 10MWT correlated excellently with the TUG
at each time point (r.0.80). However, this relationship changed over time. One year after SCI,
the time needed to accomplish the TUG was 1.25 times greater than the 10MWT time.
Discussion: Some categories of the WISCI II appear to be redundant, while some discriminate to
an insufficient degree. In addition, there appear to be ceiling effects, which limit its usefulness.
The relationship between the 10MWT and TUG is high, but changes over time. We suggest that,
at present, the 10MWT appears to be the best tool to assess walking capacity in SCI subjects.
Additional valuable information is provided by assessing the needs for walking aids or personal
assistance. To ensure comparability of study results, proposals for standardized instructions are
presented. [Neurol Res 2008; 30: 61–73]
Keywords: Standardization; instructions; guidelines; timed walking test; WISCI II; SCI; gait;
neurorehabilitation
INTRODUCTION
The need for sensitive assessment tools in the field of
neurological rehabilitation is obvious1. Current assess-
ment tools have been designed largely to document
functional outcome changes great enough to monitor
clinically relevant improvements. These large changes
are what have been considered as the most relevant for
the patients and health insurance companies, and their
assessment influences both (post-) clinical and rehabi-
litation decision making (e.g. can a patient already be
discharged from rehabilitation? Is this patient indepen-
dent enough to return to his or her home environment?).
However, today, we are full of expectations that in the
near future, new interventions will restore or repair
damaged neural structures. Therefore, assessment tools
should be able to detect smaller changes in function.
On the one hand, more sensitive tools should be
capable of detecting small improvements, thus demon-
strating possible positive treatment effects. Although
small, clinically-irrelevant treatment effects might be
considered meaningless for the patient, they could
demonstrate the ‘proof of principle’ of a new interven-
tion. On the other hand, harmful interventions could be
stopped as early as possible using more sensitive
measures, before the patient’s condition becomes
seriously affected. Thus, all of these considerations
should be taken into account when assessment tools are
evaluated on their usefulness for clinical works at
present2.
European Multicenter Study of Human Spinal Cord
Injury
The European Multicenter Study of Human Spinal
Cord Injury3 (EM-SCI; available at: http://www.ems-
ci.org) was founded in 2003. Five (at present 19) spinal
cord injury (SCI) rehabilitation centers across Europe
standardized the assessment of their acutely injured
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patients. The aims of this initiative were: (1) to
document the time course and extent of natural
recovery after SCI achieved with current rehabilitative
approaches; (2) to introduce and to validate assessment
procedures; (3) to improve diagnosis and prediction of
outcomes after SCI; (4) to prepare the clinical basis for
new interventional studies. The multicenter approach of
this project ensured the capture of a sufficient number of
cases with a broad spectrum of neurological and
functional deficits. Assessments were chosen to cover
several domains of SCI, i.e. impairment and disability.
Time points of assessments were set according to the
natural recovery and practical aspects. SCI subjects
were assessed within 2 weeks after SCI and after 1 (time
window: 16–40 days), 3 (70–98 days), 6 (150–
186 days) and 12 (300–400 days) months.
The neurological examinations encompassed the
standardized assessment established by the American
Spinal Injury Association4. In addition, neurophysiolo-
gic recordings were performed on the long sensory and
motor tracts (somatosensory evoked potentials and
motor evoked potentials, respectively) and on the
segmental level (electromyography and nerve conduc-
tion velocity). To assess the level of independence in
SCI subjects, the revised spinal cord independence
measure5 (SCIM II) was applied, while walking capacity
was assessed using the revised version of the walking
index for spinal cord injury6 (WISCI II; Figure 1), the
6 minute walk test7 (6MinWT), the 10 meter walk test7
(10MWT) and the timed up and go test7 (TUG).
There were several reasons for performing these
particular walking capacity tests. The WISCI was
already tested for validity and reliability for SCI
subjects8 and was replaced in 2001 by the WISCI II
(Figure 1)6. Indeed, valuable information can be
obtained by scoring the walking aids and/or physical
assistance needed by the patient. The three timed tests
were chosen as each of them was expected to reflect
different aspects of walking capacity. The 6MinWT was
chosen because of its relationship with cardiovascular
endurance9, while the 10MWT was chosen as a
measure to determine short duration speed that could
be relevant for in-home activities. The TUG should
relate with balance10. All tests were performed at
preferred speed, as this might reflect the level of
performance of the SCI subject in the community.
Validity, reliability and responsiveness of the WISCI II
The WISCI was carefully and specifically designed by
Ditunno and colleagues for SCI subjects8 (for a review
see ASIA/ISCOS11). Clinical experts described 19 items
based on literature review and consultation with
colleagues. These items were hierarchically rank
ordered by several international experts from the most
impaired to the least. This was followed by several
stages investigating concurrent and face validity, which
resulted finally in a group consensus. This version was
then subject to an international reliability study, in
which videotapes of a representative group of patients
was shown to several experts. Indeed, an excellent
reliability was found. In the revised scale (WISCI II;
Figure 1), two categories were added and this scale has
been used in several international works6. The WISCI II
correlated well with several other scales indicating
concurrent validity: the Barthel Index (BI) and the
Rivermead Mobility Index (RMI; for both: Spearman’s
correlation coefficient r50.67), the spinal cord inde-
pendence measure (SCIM; r50.97) and the functional
independence measure (FIM; r50.70)12. It should be
noted, however, that the SCIM, FIM and WISCI II were
retrospectively scored, based on the description of
walking in the SCI subjects charts. Furthermore, the
WISCI II correlated with the Lower Extremity Motor
Score (r50.58). It also showed good correlations with
the 6MinWT (Spearman’s correlation coefficient
r50.60), the 10MWT (r520.68) and the TUG
(r520.76)7.
Sensitivity to detect changes over time (responsive-
ness) was also investigated12. It was concluded that the
WISCI II was more sensitive to walking recovery, as the
WISCI II score distribution was wider at discharge (12/
21 items) compared to other scores (BI, 3/16 items; RMI,
2/3 items; SCIM, 5/9 items; FIM, 4/7 items). However, in
another study, the responsiveness of the WISCI II was
lower compared to the 6MinWT and 10MWT in a select
group of SCI subjects with good walking ability (WISCI
II score.1 within the first month after SCI)13. While the
timed tests could determine improvement in walking
capacity between 1 and 3 months and 3 and 6 months
after SCI, the WISCI II showed improvement only within
the first 3 months. Similar results were observed in SCI
subjects with poorer walking ability, who achieved a
WISCI II score.1 within 3 months after SCI14. In that
study, the WISCI II showed significant improvement also
between 3 and 6 months after SCI, although the median
improvement was zero.
Critical reflection of the WISCI II
The authors of the WISCI wrote that the ranking of
severity is based on the severity of the impairment and
not on functional independence in the environment6.
However, as the WISCI is applied to test an activity
(walking), it can be questioned whether ranking based
on impairment can be justified. For example, motor
impairment recovers differently compared to walking
ability15. The actual WISCI II ranking results in a
somewhat confusing order of the items and a strong
non-linearity. From a physical therapist’s point of view,
independent walking should be scored better compared
to walking that depends on the assistance of another
person7. Such aspects are not considered in the WISCI
II, as for example, category 16 (ambulates with two
crutches, no braces and no physical assistance, 10 m;
Figure 1) is scored poorer than to 17 (ambulates with no
devices, no braces and physical assistance of one
person, 10 m). Furthermore, non-linearity can be
observed if a SCI subject always needs braces. This
patient could improve theoretically from 1 to 2, 3, 5, 6,
7, 9, 10, 12, 15, to a maximum score of 18. Such jumps
in score are difficult to interpret.
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
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Reliability of the WISCI has been reported to be
excellent8. However, the authors have investigated
reliability by scoring photos or videos. This has the
disadvantage that the initial process of determining
what walking aids or physical assistance are needed
by this patient is not included in the reliability testing.
It can be considered relatively easy to observe and
score what devices and/or assistance a chronic SCI
patient uses to walk. However, at the acute stage, the
decision as to what aids or assistance the SCI patient
needs is determined by the therapist together with the
patient. This decision making process has not been
tested for reliability and might cause the most
variability in determining the appropriate WISCI II
category.
The responsiveness of the WISCI II, i.e. its ability to
detect changes over time, appears to be poor compared
to the timed walking tests. On the one hand, this could
be explained by the ceiling effect of the WISCI II: SCI
subjects that need no aids or assistance (WISCI II score
20) cannot further improve, although, for example,
walking speed might increase12,13. On the other hand,
the categories of the WISCI II can cover a broad range of
dependency. Physical assistance is described as ‘any
physical contact with the subject, including contact
guard’, which could cover a broad spectrum of physical
support. Similarly, a wide variety in braces is available
with different levels of support. Therefore, some patients
might still need braces, but smaller ones, or need
physical assistance, but considerably less and walk at a
higher speed. All this is not reflected in changes in
WISCI II category.
An assessment tool such as the WISCI II is subjected
to cultural differences. Some differences between
Figure 1: Revised version of the walking index for spinal cord injury (WISCI II) reprinted by permission from Macmillan Publishers
Ltd6
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
Neurological Research, 2008, Volume 30, February 63
Pu
bl
ish
ed
 b
y 
M
an
ey
 P
ub
lis
hi
ng
 (c
) W
. S
. M
an
ey
 &
 S
on
 Li
mi
ted
Europe and the USA are reflected in the preferences for
walking aids. For example, while axilla crutches are
predominantly used in the USA, in Europe, forearm or
Canadian crutches are more common. Forearm crutches
are considered as ‘partial bearing’ devices, because they
do not support the full weight and are primarily used to
give body stability (as opposed to leverage, like axilla
crutches provide). Furthermore, initially, the WISCI II
considered a walker to be rigid, without the use of
wheels6. However, walkers with wheels are regularly
used in European centers. Now, the WISCI II also
considers walkers with wheels, although this should be
identified in the descriptors. Similarly, other devices
used for bracing such as ace wraps or splints should be
coded as brace and described under ‘other’. In German
speaking countries, orthopedic shoes (Ku¨nzli
SwissSchuh AG, Windisch, Switzerland) are widely
used to reduce drop foot and increase lateral stability.
We suggest that these shoes should also be considered
as ‘braces’. However, should alpine boots that increase
the passive stability around the ankle–foot joint be
considered braces as well?
Furthermore, the WISCI II is subjected to new
inventions in the field of walking devices. Therefore,
the guidelines should be adapted from time to time
(as stated by the authors). For example, we were
recently confronted with a relatively new device
that provides a seat and trunk support for the
patient (Meywalk 2000, Meyland-Smith, Taars,
Denmark; Figure 2). Should this be considered as a
wheelchair that allows forward movements by the
legs (in this case, WISCI II category 0 might apply)?
Or is this a walker with wheels and additional
bodyweight support that compensates for the loss of
upper extremity supportive function in tetraplegic
patients (WISCI II category 13), as these patients need
more leg muscle strength for walking compared to
paraplegic patients15?
General validity, reliability and responsiveness of the
6MinWT
We assume that no test has been more thoroughly
investigated than the 6MinWT. The 6MinWT was
originally applied to patients with respiratory diseases
and chronic heart failure9,16. In the cardio-respiratory
domain, the 6MinWT is the test of choice17,18. Indeed,
in patients with primary pulmonary hypertension, the
distance walked during 6 minutes correlated strongly
with peak oxygen levels19. Also in patients with chronic
obstructive airways and asthma, the 6MinWT correlated
significantly with lung volume measurements20. This
might be the reason why the 6MinWT has been applied
to many different subject groups, with the aim of
assessing cardiovascular endurance.
The 6MinWT has been tested for reliability in
different patients groups. The 6MinWT is considered
reliable when tested in healthy children21 and elderly
subjects22, as well as in subjects with stroke23,24,
acquired brain injury25,26, cerebral palsy27, fibromyal-
gia28,29, multiple sclerosis30 and cardiopulmonary
disease31,32.
In patients with heart failure, the responsiveness of
the 6MinWT is controversially discussed. In the
RESOLVD study, the quality of life measures showed
better responsiveness than the 6MinWT32, while the
responsiveness was considered good in elderly patients
with heart failure33. In patients with chronic obstructive
pulmonary disease, the endurance shuttle walking test
was found to be more responsive compared to the
6MinWT34. Elderly subjects who underwent a func-
tional training program showed less change in 6MinWT
compared to a physical performance test35. However,
the 6MinWT showed good responsiveness in patients
with fibromyalgia29. The best initial estimates of small
meaningful changes in elderly subjects were near 20 m
and of substantial change near 50 m for 6MinWT36. For
clinical use, small changes in the distance walked
during 6 minutes are detectable36.
Validity, reliability and responsiveness of the 6MinWT in
SCI patients
The 6MinWT has been applied to SCI patients in
several works7,11,13,37–42. Concerning construct validity,
the strength of the hip flexors at the less affected side
correlated well with the distance walked during
6 minutes39. Bilaterally, hip flexor and abductor muscle
strength correlated best with the 6MinWT and gait
speed39. A concurrent validity study showed that the
6MinWT correlated well with the WISCI II (r50.60), the
10MWT (r520.95) and the TUG (r520.88)7.
While inter-rater reliability can be considered good,
intra-rater reliability showed an improved 6MinWT
performance between the first and second trial7.
The responsiveness of the 6MinWT can be considered
good in SCI subjects. Chronic SCI subjects who under-
went a locomotor training program using a driven gait
orthosis improved their distance walked during 6 min-
utes and gait speed, while the WISCI II showed no
change41. In addition, in a small group of SCI subjects,
Figure 2: Meywalk 2000 walking aid: WISCI II category 0 or 13
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
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both the 6MinWT and the 10MWT improved between 1
and 3 months and 3 and 6 months after SCI, while the
WISCI II showed improvement only between 1 and
3 months13.
Critical reflection of the 6MinWT
The standardization of the 6MinWT is more difficult
compared to the 10MWT, as it depends strongly on the
facilities. In some works, the subjects performed the
6MinWT by walking up and down a pathway of a
specific length. This has the advantage that it could also
be applied in settings with limited space. However,
walking speed might be negatively influenced by the
turns. Indeed, in stroke patients who had to walk up and
down, the 10MWT speed overestimated the 6MinWT
speed43, while when they walked in a square, the
speeds were comparable44. Therefore, this test should
be performed with the least amount of turns possible.
Furthermore, as encouragement had a substantial
impact on the distance walked during 6 minutes in
both cardiac and the respiratory patients9, the test
instructions should be rigorously standardized.
Although the reliability of the 6MinWT has been
reported to be high, several works indicated that the
6MinWT performance improved significantly after the
first trial in healthy subjects45 as well as in patients with
cerebral palsy27, fibromyalgia29, SCI7 and cardiopul-
monary problems9,31. It is therefore recommended that
the subjects perform at least one test trial, before
performing the actual measurement.
The 6MinWT appears to be redundant in some groups
of patients with neurological disorders. Patients with
stroke44 and SCI14,39 showed no difference between
short duration walking speed and speed during
6MinWT. This was even the case when tested at
maximum walking speed14. It might indicate that in
patients with neurological deficits, the distance walked
during 6 minutes is not limited by cardiovascular
impairments, but by other deficits, for example,
sensorimotor deficits. Indeed, in patients with stroke,
there was no relationship between the 6MinWT and
cardiovascular endurance46. Even in patients with
severe lung diseases, the 6MinWT was rather related
to muscle function than to cardiac or ventilatory
impairment47.
A selection bias could occur, as not all patients who
are able to walk (WISCI II.1) perform the 6MinWT.
Physical therapists tend not to test subjects who have
poor walking ability, although these patients are
allowed to take a rest during the 6MinWT. Especially
at onset of the rehabilitation, this leads to a small
number of patients who have performed the 6MinWT.
Thus, especially in patients with poor walking ability, a
discrepancy might exist between short and long dura-
tion walking speed, which has not been assessed so far.
General validity, reliability and responsiveness of the
10MWT
The 10MWT represents a quick and easy measure and
can be applied to any population able to ambulate the
required distance11. Reference values for gait speed
exist for different ages and gender, although these were
not derived from 10 meter testing48. The 10MWT was
subject to concurrent or construct validation. It has been
applied to both healthy subjects (e.g. elderly subjects49)
and different patient groups with neurological disorders
such as Parkinson’s disease50,51, stroke52–54 and multi-
ple sclerosis55. In patients with cerebral glioma, the
10MWT correlated well with the BI56. In children with
neuromuscular disease, the 10MWT correlated well
with a 10 minute walk, although the self-selected speed
was higher for the 10MWT57. It has also been applied in
patients with orthopedic disorders, e.g. with lower limb
amputation58. Patients with a transtibial amputation
walked faster compared to those with a transfemoral
amputation59.
The 10MWT showed good reliability in patients with
mixed neurological diagnoses (ICC50.93)60, stroke52,
multiple sclerosis30 and Parkinson’s disease50.
The 10MWT also showed good responsiveness in
acute stroke patients53,61,62, although the 5 meter walk
test appeared to be more responsive compared to the
10MWT63.
Validity, reliability and responsiveness of the 10MWT in
SCI patients
Concerning construct validity, the strength of the hip
flexors at the less affected side correlated well with gait
speed39. Bilaterally, hip flexor and abductor muscle
strength showed the highest correlations with gait
speed39. Concerning concurrent validity, the 10MWT
correlated well with the 6MinWT (r520.95), TUG
(r50.89) and WISCI II (r520.68)7. Compared to the
TUG and 6MinWT, it showed better inter- and intra-
rater reliability in SCI, as the subjects’ gait speed did not
change between the first and second trial7. The 10MWT
was more responsive than the WISCI II in SCI subjects. It
assessed changes during SCI rehabilitation between 3
and 6 months after SCI13 and in chronic SCI, it detected
improvement in gait performance due to automated
treadmill training41, both unrevealed by the WISCI II.
Critical reflection of the 10MWT
Walking speed is considered as a surrogate for the
overall quality of gait (and motor function)44. However,
gait speed is difficult to interpret. What is a meaningful
gait speed for daily life and which increment in speed
can be considered relevant? Gait speed has not been
correlated with disability scales in SCI. It is therefore
difficult to determine its relevance for daily life. The
speed needed to safely cross a street was found to be
0.6 m/s64. This was used to separate SCI subjects into
functional and non-functional walkers. In elderly sub-
jects, among several variables, a walking speed above
1.0 m/s was associated with an independent lifestyle65.
Perera et al.36 found in elderly subjects that the best
estimates of small, meaningful changes in gait speed
were near 0.05 m/s, while substantial changes were
near 0.10 m/s.
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
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Similarly to the 6MinWT, the 10MWT has a floor
effect for those subjects who are unable to walk 10 m.
In addition, a ceiling effect might occur for those
subjects who can walk a longer distance at the same
speed. The latter effect is expected to be less for the
6MinWT.
In stroke, it has been shown that the 10MWT speed
overestimated the long distance walking speed43. This
was also the case for children with neuromuscular
disease57. However, in a recent study, these findings
could not be confirmed for SCI subjects14. The 10MWT
speed did not differ from the 6MinWT speed 1, 3 and
6 months after SCI. This is in line with a recent study in
stroke44.
General validity, reliability and responsiveness of the
TUG
The get up and go test66 was modified by introducing
a timed component (TUG)10. The test was validated in
frail, elderly subjects and was shown to correlate
moderately with gait speed, the Berg balance scale
and the BI10. Concurrent validity was good in patients
with chronic stroke67. In patients with multiple sclero-
sis, the TUG correlated well with other static and
dynamic balance tests, although all tests showed poor
discriminative ability between fallers and non-fallers68.
The discriminative ability of the TUG to predict falls was
good in subjects with stroke69, but contradicting
findings exist in community-dwelling elderly peo-
ple70,71. The TUG could discriminate between geriatric
subject groups who used different walking aids72. In
children, the TUG could differentiate well between
children with cerebral palsy or spina bifida and healthy
ones, as well as between children of different ages73.
Good concurrent validity was found in patients with
lower limb amputation74.
Reliability was excellent in young73 and elderly49,70
healthy subjects, as well as in subjects with Parkinson’s
disease75, chronic stroke67 and lower limb amputa-
tions74. Reliability was poorer in patients with total hip
and knee arthroplasties76 and in elderly subjects,
cognitive impaired or unimpaired77.
The responsiveness of the TUG was good in young
children in that it detected change over a period of five
months73. It was also responsive in older subjects
participating in geriatric rehabilitation72. It also detected
deterioration and improvement in the early post-
operative period after total hip and knee arthroplasty76.
In patients with acute stroke, the responsiveness of the
TUG was less compared to, for example, the 5 meter
walk test63.
Validity, reliability and responsiveness of the TUG in SCI
patients
Concurrent validity is good as a strong correlation
was found between the TUG and the WISCI II
(r520.76), the 6MinWT (r520.88) and the 10MWT
(r50.89)7. Reliability was high (r.0.97), but the Bland–
Altman analysis showed that SCI subjects performed the
second trial better than the first one, when tested by the
same rater7. To our knowledge, no information exists
about the responsiveness of the TUG in SCI subjects.
Critical reflection of the TUG
In patients with Parkinson’s disease50,75 or SCI7, test
performance increased between the first and second
trial, which influences reliability. It is therefore recom-
mended that similarly to the 6MinWT, the subjects
should perform a test trial at least once before
performing the measurement.
The TUG correlated excellently with the 10MWT,
which might indicate redundancy7.
A slight disadvantage of the TUG is that it cannot be
converted into speed, as can be carried out with the
10MWT and 6MinWT. The speed of subjects unable to
perform the 10MWT or 6MinWT can be set at 0 m/s.
This is not possible for the TUG and makes statistical
analyses more difficult.
An advantage of the TUG is that a more complex task
is tested rather than ‘just’ walking, which might better
reflect daily life activities. However, as it combines
several important tasks in one test, it scores the whole
composite of standing up, walking, turning and sitting
down, which might decrease the sensitivity of the
information gained. It might be more accurate to test the
different phases separately: the sit-to-stand-to-sit test
could be performed to test standing up and sitting
down78–80. As this test should be performed with
crossed hands, it might be more related to upper leg
strength than the TUG, in which the subject can use the
arms when standing up and sitting down. Walking could
be tested by the 10MWT. Turning might be tested by
timing and counting the number of steps needed to turn
360u, which has successfully been applied to elderly
people81 and patients with Parkinson’s disease82.
Aims of this study
This overview shows that the assessment of walking
capacity has been extensively investigated in a variety
of patient populations, but much less assessed in SCI
patients. The aims of this study were to investigate: (1)
which WISCI II categories apply to the EM-SCI subjects;
(2) the relationship between the TUG and the 10MWT,
as results from a previous study7 might suggest that these
tests provide similar information.
METHODS
Retrospective analyses were performed of the EM-SCI
database. At the time of analysis, the EM-SCI database
contained data from 917 subjects. The numbers of
missing observations were the largest 2 weeks (difficult
to asses at this early time point in most European
centers) and 12 months (unfinished follow-up) after SCI.
To investigate which WISCI II categories applied to the
SCI subjects, the frequency of each category was
presented as a percentage for each time point. The
percentages of each WISCI II category were averaged
for all time points.
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
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The walking tests were applied by trained physical
therapists. The SCI subjects performed the 10MWT with
a ‘flying start’, i.e. they walked y14 m, while the
intermediate 10 m were measured to compensate for
acceleration and deceleration effects. The TUG was
performed according to a previous study10. However,
the SCI subjects initiated the test themselves, instead of
responding to a ‘go’ signal. The relationship between
the 10MWT and the TUG was investigated using linear
regression and correlation analyses. Again, separate
analyses were performed for each time point.
RESULTS
Several WISCI II categories (Figure 1) applied rarely to
the EM-SCI subjects (Table 1). Each of the categories 2,
7, 10, 14 and 18 applied on average to less than 1% of
the SCI subjects with some walking ability (WISCI II.0;
final column in Table 1). In addition, the categories 3, 6,
11, 15, 17 and 19 applied to less than 2% of the SCI
subjects with a WISCI II above 0. These 11 categories
applied to 11% of walking EM-SCI subjects. In contrast,
a large proportion (71%) of the SCI subjects with some
walking ability could be categorized into the items 1, 8,
13, 16 and 20.
Relationship between TUG and 10MWT
The relationships between the TUG and the 10MWT
are shown in Figure 3. The non-parametric correlations
(chosen to adjust for outliers) varied between 0.81 and
0.96. Two weeks after SCI (Figure 3A), according to the
linear regression model, 96% of the variation in TUG
could be explained by knowing the variation in the
10MWT results (this is the explained variance;
Figure 3F). However, as the number of observations
was small, the non-parametric correlation might be
more applicable. One month after SCI (Figure 3B), the
linear regression model showed the poorest explained
variance. Over half of the variation in TUG could be
explained by knowing the 10MWT results. The equation
(Figure 2F) showed that considerably more time was
needed to perform the TUG compared to the 10MWT
(11.6 secondsz 0.68 times the time needed to perform
the 10MWT). Three and 6 months after SCI
(Figure 3C,D), similar results were obtained. The
explained variance was y75% and the time needed
to perform the TUG was still longer compared to the
10MWT. However, it decreased y2 seconds from 3 to
6 months after SCI. Finally, 12 months after SCI
(Figure 3E), the TUG was found to take 1.25 times
longer than the 10MWT.
Table 1: Frequencies of WISCI II categories
WISCI II
2 weeks 1 month 3 months 6 months 12 months Average*
n % n % n % n % n % %
0 504 646 485 333 213
1 5 18.5 15 10.0 13 5.2 6 2.8 1 0.6 7.4
2 0.0 0.0 0.0 0.0 0.0 0.0
3 1 3.7 2 1.3 4 1.6 2 0.9 1 0.6 1.6
4 2 7.4 12 8.0 12 4.8 5 2.3 2 1.1 4.7
5 2 7.4 8 5.3 10 4.0 10 4.6 1 0.6 4.4
6 0.0 6 4.0 7 2.8 2 0.9 1 0.6 1.7
7 0.0 1 0.7 3 1.2 1 0.5 2 1.1 0.7
8 3 11.1 11 7.3 18 7.3 18 8.3 6 3.3 7.5
9 1 3.7 5 3.3 7 2.8 11 5.1 2 1.1 3.2
10 0.0 0.0 2 0.8 0.0 0.0 0.2
11 1 3.7 5 3.3 2 0.8 4 1.8 0.0 1.9
12 0.0 3 2.0 22 8.9 15 6.9 14 7.8 5.1
13 1 3.7 18 12.0 22 8.9 14 6.5 11 6.1 7.4
14 0.0 0.0 2 0.8 2 0.9 1 0.6 0.5
15 0.0 0.0 3 1.2 3 1.4 4 2.2 1.0
16 0.0 9 6.0 26 10.5 26 12.0 21 11.7 8.0
17 0.0 7 4.7 1 0.4 4 1.8 1 0.6 1.5
18 0.0 0.0 0.0 0.0 3 1.7 0.3
19 0.0 0.0 5 2.0 5 2.3 8 4.4 1.8
20 11 40.7 48 32.0 89 35.9 89 41.0 101 56.1 41.2
Total 531 796 733 550 393
Missing 386 121 184 367 524
Grand total 917 917 917 917 917
*The average percentage was calculated over all five time points for those SCI subjects with a WISCI II score.0 (some ability to stand or walk). n,
number; %, the percentage of SCI subjects that have a WISCI II score.0.
Assessment of walking capacity in SCI: H. J. A. van Hedel et al.
Neurological Research, 2008, Volume 30, February 67
Pu
bl
ish
ed
 b
y 
M
an
ey
 P
ub
lis
hi
ng
 (c
) W
. S
. M
an
ey
 &
 S
on
 Li
mi
ted
DISCUSSION
The main findings of this study were the following: (1)
many EM-SCI subjects were categorized in a limited
number of WISCI II items, while half of the WISCI II
categories applied to a small number of subjects; (2) in
general, the TUG correlated excellently with the
10MWT, but the relationship changed over time.
As the rehabilitation process continued, the number
of SCI subjects with a low WISCI II score tended
to decrease, while higher WISCI II scores applied
more frequently to the EM-SCI subjects. The items 1,
8, 13, 16 and 20 applied frequently to SCI subjects
with walking ability. These findings are in line with
those from Morganti et al.12, who found that most
Figure 3: Relationships between TUG and 10MWT. Scatter plots showing the relationships between the timed up and go (TUG) and
10 meter walk tests (10MWT) 2 weeks (A), 1 month (B), 3 months (C), 6 months (D) and 12 months (E) after spinal cord injury. Please
note the logarithmical scale and the differences in scales between the figures. More detailed information about the regression analysis
is provided in F. r, Spearman’s non-parametric correlation coefficient; *p,0.05; ***p,0.001; N, number of observations; R2adj.,
adjusted explained variance; lower and upper limits of the 95% confidence interval (95% CI) are presented for the constant b0 and
the regression coefficient b1 of the regression equation y5b0 z b1 6 x
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walking SCI subjects could be scored 13, 16 or 20 after
rehabilitation.
In contrast, about half of the WISCI II categories
applied to 11% of the EM-SCI subjects. Redundancy of
the WISCI II has already been previously addressed12, as
the WISCI II correlated excellently with the SCIM II
mobility category for short distances. The high correla-
tion of 0.97 indicated that 94% of the variation of the
WISCI II (which has 21 items) could be explained by the
SCIM II (which has nine items)12. The present results
indicate that if a shorter version of the WISCI II would
be desired, the categories 1, 4, 5, 8, 9, 12, 13, 16 and
20 (Figure 1) could describe the appropriate need of
physical assistance and/or walking aids in 80.9% of the
EM-SCI subjects with some walking ability.
Relationship between TUG and 10MWT
Although the TUG and the 10MWT correlated
excellently with each other, the relationship was not
fixed, but changed over time. The time needed to
perform the TUG (compared to the 10MWT) decreases
over time. Especially 1 month after SCI, the TUG might
provide additional information, as only half of the
variation in the 10MWT could explain the variation of
the TUG. This difference might be related to an impaired
balance, which is suggested to be related to the TUG10.
However, over time, the TUG might become redundant
as at least 75% of the variation in the TUG is covered by
the 10MWT results. In the chronic stage (1 year), the
TUG can be estimated by multiplying the time needed
for the 10MWT by 1.25 times.
Figure 4: Proposals for standardization of the timed walking tests. Proposed instructions for the (a)
6 minute walk, (b) 10 meter walk and (c) timed up and go tests performed at (A) preferred and (B)
maximum walking speed
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Aspects of walking capacity
In SCI subjects, the assessment of walking capacity is
relatively new and information is lacking. For example,
maximum walking speed has rarely been tested in SCI
subjects14,83. The preferred walking speed of SCI
subjects may only partially reflect the potential to
participate in the community. Maximum walking speed,
for example, which may be needed to catch a bus or
cross a street, might be a better measure of daily life
ambulatory capacity. Furthermore, walking capacity is
tested in a simplified environment (i.e. a well lit
corridor, straight path, no disturbing factors, etc.), which
might be less applicable to daily life. New tests might
assess the capacity to adapt walking to external
demands (walk over uneven floors, ascend or descend
slopes, avoid obstacles) or evaluate the influence of
attention84 on walking, by applying the dual task
approach.
Furthermore, depending on the research question,
different aspects of walking capacity might be relevant.
For example, the application of functional electric
stimulation to improve walking ability is still controver-
sially discussed85. However, FES systems are improving
and might allow independent walking for subjects who
are normally wheelchair bound86. One goal could be to
increase the maximal non-stop covered walking dis-
tance for SCI subjects (unrestricted for time). However,
at present, we are unfamiliar with an appropriate
standardized test protocol.
Standardization of walking tests
To ensure comparability of results (especially in
multicenter trials), rigorously standardized assessment
protocols are needed. We therefore propose instructions
for the walking capacity tests discussed in this study and
hope that these proposals might initiate a discussion
concerning the standardized assessment of walking tests
in the field of SCI and perhaps even in rehabilitation in
general.
WISCI II
While at present different instructions are available
for the use of timed walking tests, there are clear
guidelines available for the WISCI II at: http://www.
spinalcordcenter.org/research/wisci/resources/wisci-guide.
pdf
The scoring form and descriptors are available at:
http://www.spinalcordcenter.org/research/wisci/resources/
wisci-scoring-form.pdf
Timed walking tests
If more than one test is applied during a single
session, we propose to perform the less fatiguing test
first (e.g. preferred walking speed test before maximum
speed test, or the 10MWT before the 6MinWT).
Sufficiently long rest periods between each test should
be taken and dress shoes should not be allowed87. We
suggest that the patient initiates the test and not that he/
she should react on a ‘go’ signal, as we do not intend to
measure reaction time. A stopwatch with an accuracy of
1/10 seconds is required. In addition to the timed tests,
the WISCI II can be used to score the need for walking
aids and assistance. For all tests, the investigator should
be positioned next to the patient. In this way, the
beginning and end point of the timed pathway can be
better determined and assistance can be provided if
required.
6MinWT
The environment for 6MinWT might be difficult to
standardize. A flat, smooth, non-slippery surface, with
no disturbing factors, is required and the pathway
should contain as few turns as possible (preferably a
large round or oval shaped path). Distances should be
marked at least every 5 m. The total distance should be
written down in meters.
Subjects are instructed to walk at their preferred (or
maximum) walking speed (Figure 4a). The subject
initiates the start of the test. After each minute, the
subject should be informed about the time left and
should be encouraged to continue his/her performance
(Figure 4a).
Remarks
(1) If subjects are unable to walk for 6 minutes, rest
breaks are allowed. After resting, the subject might
continue with the test and the final distance is
determined after 6 minutes. In such a case, a remark
about the rest period should be written down; (2) it will
be difficult to assess a 6 MinWT in subjects who are
categorized to WISCI II scores of 2–5, as these subjects
depend on parallel bars.
10MWT
The environment should be similar to that for the
6MinWT. The subjects are instructed to walk 14 m,
while the intermediate 10 m should be marked on the
floor. The measurement starts when the patient crosses a
mark on the floor that indicates the onset of the 10 m
pathway (‘flying start’). After 10 m (32.8 feet), the timer
is stopped, but the patient continues until he or she has
reached the end of the 14 m track. The time is written
down to an accuracy of 1/10 seconds. Subjects are
instructed to walk at their preferred (or maximum)
walking speed (Figure 4b).
Remarks
(1) A special condition occurs when the patient
requires the use of parallel bars, as these are rarely 14 m
long. We suggest recording the middle 5 m between the
parallel bars twice. The time of the first and second 5 m
distances are summed and written down; (2) this test
application is comparable to the 50 feet test that has
sometimes been used in SCI patients37, although time is
only recorded for 10 m.
TUG
In general, we would suggest using most of the
instructions of the modified TUG test as proposed by
Podsiadlo and Richardson10. However, we propose that
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the subject should initiate the test (Figure 4c).
Comparable to the 10MWT, a similar environment of
at least 4 m long is required. The chair should have a
seat height of 46 cm and armrests (67 cm). The patient
sits with his or her back against the chair, arms resting
on the chair’s arm. As soon as the subject lifts up from
the chair (buttocks), the time recording starts. The
subject may use the armrests of the chair for support.
After 3 m (9.8 feet), the subject turns and walks back to
the chair. The timer is stopped as soon as the buttocks
touch the chair again. The time is recorded and written
down at 1/10 second accuracy.
CONCLUSION
There is a need for valid, reliable and responsive tests to
assess walking capacity in SCI subjects. Clinically
relevant changes in walking ability are important for
the individual patient, while sub-clinical changes (on
the population and individual level) become important
when new treatments are evaluated for efficacy and
safety. We presented four walking tests that are applied
in the EM-SCI. We presented their positive and negative
aspects, as well as new results showing that most SCI
subjects could be categorized into a limited number of
WISCI II items and that the TUG correlated well with
the 10MWT, but that this relationship changed over
time. We suggest that, at present, the 10MWT might be
the best choice for assessing walking capacity in SCI
subjects. Furthermore, we recommend the additional
assessment of the dependence of the SCI subjects on
walking aids or personal assistance.
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